Biogen scores FDA approval for generic eye disease biologic

The Cambridge drugmaker has nabbed an approval from the U.S. Food and Drug Administration for a biosimilar that can treat three disorders causing progressive blindness.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news